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Abstract—Many organs of higher organisms are heavily
branched structures and arise by an at first sight similar process
of branching morphogenesis. Yet the regulatory components and
local interactions that have been identified differ greatly in these
organs. It is an open question whether the regulatory processes
work according to a common principle and in how far physical
and geometric constraints determine the branching process. Here
we review the known regulatory factors and physical constraints
in lung, kidney, pancreas, prostate, mammary and salivary gland
branching morphogenesis, and describe the models that have
been formulated to analyse their impacts.
Index Terms—branching; computational modelling; in silico
organogenesis
Branching Morphogenesis is observed in many organ sys-
tems (figure 1) and in many different species. The branching
process in the mammalian lung (figure 1a) and in its analog
in flies, the trachea, has been studied in particular great detail.
The bronchial tree arises from the sequential use of three geo-
metrically simple modes of branching: domain branching (fig-
ure 2a), planar (figure 2b), and orthogonal bifurcation (figure
2c) [1]. Trifurcations (figure 2d) have also been documented in
the lung [2], but these are much more prevalent in the ureteric
bud of the kidney (figure 1b): in the kidney bifurcations and
trifurcations dominate, at the expense of lateral branching
[3]–[5]. Similar modes of branching are observed also in
glands (figure 1c-f). In this review we will focus on branching
during mammalian organogenesis, but ignore neuronal and
vasculature branching as well as branching observed in plants.
For reviews of these branching systems we refer to [6]–[10].
Most processes in higher organisms are intricately regulated
by a network of signalling factors. To arrive at a branched
structure these signalling components would have to form
a pattern in space that precedes bud outgrowth as indeed
observed in case of fibroblastic growth factor (FGF) 10 in the
developing lung bud (figure 3a,b). The concentration of FGF10
at the distal tip of the lung bud would then direct elongation
(figure 3c), while terminal branching would be the result of a
split localisation of FGF10 (figure 3d), and lateral branching
would result from FGF10 signalling being restricted to spots
on the side (figure 3e).
Such patterns can, in principle, emerge from a pre-pattern
that goes back to earlier phases of embryonic development
or that arises spontaneously from regulatory interactions. A
number of theoretical models have been developed to explain
Fig. 1: Branching Morphogenesis. Typical branching pattern
over developmental time in the (a) lung, (b) ureteric bud, (c)
salivary gland, (d) prostate, (e) mammary gland, and (f) the
pancreas. The epithelium is shown in black, the mesenchyme
in red, the fat pad in the mammary gland in green, and and
the lumen in the pancreas in yellow.
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Fig. 2: Modes of Branching. (a) Lateral branching, (b) planar
bifurcation, (c) orthogonal bifurcation, (d) trifurcation. Panels
(a)-(c) were reproduced from [6].
how patterns can emerge and how these are read out in space.
We will review these concepts in the context of their use in
the models for branching morphogenesis.
While the branching patterns are overall similar, there are
important differences (figure 1), and the signalling proteins
that control the branching program in the different organ
systems are not always the same (figure 4). Thus FGF10
appears to drive outgrowth of lung buds [11], prostate [12]
(both figure 4a), salivary glands [13], [14] (figure 4b), and
pancreatic buds [15], [16] (figure 4c), while ureteric bud
outgrowth is controlled by the TGF-beta family ligand Glial-
derived neurotrophic factor (GDNF) (figure 4d) [17]–[20], and
no single growth factor has yet been defined for the mammary
gland [7], though FGF receptor 2 is known to be required for
ductal elongation in mammary glands [21]. These signalling
proteins are controlled by further proteins and the regulatory
networks differ between organs. Given these differences in the
signalling networks, also mechanisms based on the interplay
of physical forces have been explored.
Key to all such mechanisms is an instability which results in
a patterning and/or a symmetry breaking event. The elongating
tube can be regarded as a cylinder with a cap (figure 5). A
cylinder with a homogenous distribution of morphogens on
its surface has a cylindrical symmetry, i.e. if the cylinder
is rotated by any angle along the main axis the pattern
will not change (figure 5). During branching morphogenesis
a symmetry breaking event must occur because the out-
growing bud has approximately cylindrical symmetry while
the branching events (i.e bifurcations, trifurcation or lateral
branching) change the cylindrical symmetry into a rotational
symmetry. Symmetry breaking is a fundamental process and
occurs multiple times and at various scales during embryo
development as recently reviewed in the collection of Cold
Spring Harbor Perspectives in Biology; for the editorial see
[22].
Computational models can help to explore the impact of the
signalling interactions, physical forces and domain geometries
and thus discern a minimal set of rules and interactions from
which the observed pattern can emerge. In the following
we will discuss the different models that have been applied
to branching morphogenesis of various organs. We will be
interested, in particular, in how far similar mechanisms can
explain branching morphogenesis in different organ systems.
Fig. 3: FGF10 in the developing lung. (a,b) Fgf10 expression
at embryonic day (E) 12.5. High expression levels of Fgf10 are
observed in the distal mesenchyme of the tip (white arrow), as
well as on the sides of the tips of a bud (white arrowheads).
(b) High magnification of the white dotted box in panel a.
Note that Fgf10 expression is absent in the mesenchyme
adjacent to the endoderm (en) of the tip. Localized Fgf10
expression is also observed in the mesenchyme around the
stalk (black arrowhead). (c-e) Schematic representations of
the spatial distributions of Fgf10 expression in panels a,b.
Fgf10 is expressed in the red region. The white area indicates
the lumen, the grey area the mesenchyme, the black line
in between the epithelium. The outer black lines marks the
mesothelium. The three types of spatial distributions of Fgf10
expression generate different branching modes: (c) elongation,
(d) terminal bifurcation, and (e) lateral budding. The figure and
the legend were adapted from [23]; panels a and b were taken
from the original publication [11].
I. LUNG BRANCHING MORPHOGENESIS
Early lung branching morphogenesis is stereotyped and the
lung tree arises from the sequential use of three geometrically
simple modes of branching: domain branching, planar and
orthogonal bifurcation [1]. Transitions from one mode to
another are restricted to four routines and lead to three defined
sequences which are used to build the entire lung tree [1], [6].
In the domain branching mode, the lung bud elongates and
new buds appear first on one side of the stalk in a direction
perpendicular to the main axis of the cylinder and subsequently
on another side of the stalk. Planar and orthogonal bifurcations
represent two consecutive rounds of bifurcations and differ
in the second round of branching, which occurs in the same
plane in case of planar bifurcations and orthogonal to the
first plane in case of orthogonal bifurcations [1]. Trifurcations
(figure 2d) have also been documented recently [2]. The
domain branching mode is utilized to build the backbone of
the respiratory tree, whereas planar bifurcations form the thin
edges of the lobes, and orthogonal bifurcations create the lobe
surfaces and fill the interior. Only few variations and errors are
observed in wild-type littermates [1], [2]. The regularity of the
Fig. 4: Signalling networks in branching morphogenesis. The core signalling networks that have been described to regulate
branching morphogenesis in (a) lung and prostate, (b) salivary gland, (c) pancreas, and (d) kidney. In the lung, prostate, salivary
gland, and pancreas FGF10 (F) signalling directs outgrowth of the epithelium. Fgf10 is expressed in the mesenchyme (grey) and
binds to its receptor (R) in the epithelium (red). FGF10-bound receptor not only directs outgrowth, but also regulates expression
of Shh (S) ((a) upregulation in the lung and prostate, (b) downregulation in the salivary gland, (c) no reported regulation in
the pancreas). SHH binds its receptor PTCH1 (P) and the SHH-receptor complex, in turn, regulates Fgf10 expression ((a,c)
downregulation in the lung, prostate, and pancreas, (b) upregulation in the salivary gland). All ligand-receptor signalling also
upregulates the expression of the receptor. (d) In case of the ureteric bud, GDNF (G) induces bud outgrowth and GDNF-receptor
binding stimulates expression of the receptor Ret and of Wnt11 (W) in the epithelium. WNT11, in turn, causes upregulation
of Gdnf expression in the mesenchyme.
process implies that the branching process is not random, but
tightly controlled by genetically encoded information. It is an
open question how a stereotyped branching architecture with
millions of branches can be encoded with only a few genes.
A. Fractals
Fractals are complex structures that can be formed by the
repetitive application of a set of simple rules. If the lung was
a fractal structure then its complex architecture could result
from a set of simple rules as has been demonstrated in many
fractal models of the lung. The most sophisticated and accurate
of these models was created by Kitaoka and colleagues who
required nine basic and four complementary rules to fill the
3-dimensional thoracic cavity with a branched tree that very
much resembled that of the lung (figure 6, [24]).
To judge whether a geometric figure is indeed a fractal
we need to check whether the geometric figures repeat them-
selves at progressively smaller scales. In case of the lung,
dichotomous branching gives rise to two daughter branches
with smaller diameter than the mother branch. To obtain a
fractal series the shrinkage factor would need to be the same
in all generations.
Both the length and the diameter of lung branches have
been determined for the adult lungs of several mammals [25].
The ratio between diameter and length differs between species,
but it is conserved in a given specie (i.e. length / diameter ∼
3 in humans) [26]. We can therefore focus on the diameter.
Measurements show that the diameter dz of the lung branches
in generation z decrease exponentially with the branching
generations (figure 7). More formally we can write
dz = d0 exp (−αz) = d0qz, α = − ln q (1)
where q = exp (−α) < 1 is a constant scaling factor. We can
rewrite this equation as
dz = qdz−1.
The diameter and length in each subsequent generation thus
decreases by a constant factor q < 1. Such constant scaling law
Fig. 5: Patterning and symmetry break. A cylinder with
a homogenous morphogen concentration exhibits cylindrical
symmetry. Patterning mechanisms may introduce stripes or
spots. The spotty cylinder exhibits rotational symmetry, and
such pattern would support the outgrowth of defined branches.
Fig. 6: A 3-dimensional fractal model of an airway tree
with 54,611 branches; branches distal to different segmental
bronchi are shown in same color as segmental bronchus. (a):
anterior view. (b): right lateral view. The figure and legend
were adapted from [24].
reflects the scale invariance of fractal patterns, i.e. the pattern
looks the same no matter on what scale of the structure we
zoom in.
In the next step we can determine the fractal dimension of
the lung. In the classical interpretation, dimension corresponds
to the number of independent coordinates that are required to
describe the position of an object in that particular space. To
determine a fractal dimension we need to use the so-called
Haussdorff dimension. First consider a square. If we scale
down each side by a scale factor r = 1/2, then we require 22
squares to fill the original square. With r = 1/n we require
n2 squares. In 3 dimensions we would require n3 cubes. More
generally, if we scale down each side by scale factor r = 1/n
we require m = 1r
D
= nD elements to fill the original space.
D is the dimension.
m =
(
1
r
)D
⇔ D(r) = lnm(r)
ln 1/r
Branching in the lung is dichotomous, and from generation
to the next m = 2 elements thus emerge. The diameter
is scaled by q = exp (−α) = 2−1/3 in the first 10-15
generations that generate the conducting airways, i.e. for the
airways, which do not participate in gas exchange (figure 7).
Accordingly, the fractal dimension of the lung would be
Dfractal =
lnm
ln 1/q
=
ln 2
ln 21/3
= 3,
which would imply that the airway tree fills the entire 3-
dimensional thoracic space. Fractal properties in nature have
remained controversial because, unlike in mathematical se-
quences, the geometric figures are observed over a small,
finite scale (number of generations) and fitted scaling factors
are therefore not particularly reliable [27]. In fact, a different
scaling factor is observed for the lower, respiratory branches
(figure 7, acinar airways), and attempts to simultaneously fit
both series have led to a different scaling factor [28], and to
the suggestion of a power-law relation [25].
There is, however, independent strong support for the frac-
tal properties of the branching structure of the conducting
airways. Thus the required diameter relation dz = 2−z/3d0
in the conducting part of the airways has been shown to
result in an airway architecture that permits breathing with
minimal energy wastage (entropy generation) by minimizing
the combined effects of dead volume and resistance [29].
Thus the upper part of the lung is dead volume because
it must be ventilated without contributing to gas exchange
with the blood. The larger the diameters in this part of the
structure, the larger the dead volume, and thus the more
energy is wasted in each breath. However, shrinking these
diameters results in an increase in air flow resistance. The
diameter relation dz = 2−z/3d0 is the one that minimizes
the combined contributions of these two effects. The fractal
organization of the conducting parts of the bronchial tree
thus permits the generation of a space-filling, energy-efficient
architecture for ventilation, where all the tips have similar
distances from the origin of the airways in the trachea, based
on a simple set of rules. While this may explain why such
a bronchial tree evolved, it does not reveal the driving force
during development since the embryo does not breath and the
developing lung is filled with fluid rather than air. Moreover,
the diameters and lengths in early lung development do not
yet exhibit a fractal pattern. So what are the mechanisms that
regulate branching morphogenesis?
B. Mechanical Models
Culture experiments demonstrate that the mesenchymal tis-
sue largely defines the branching pattern when mesenchymal
tissue and epithelial tissue of different organs are combined.
One striking example came from tissue recombination exper-
iments in which lung mesenchyme induced branching of the
Fig. 7: A fractal-like organization of the lung. A logarithmic
plot of the airway branch diameter against the branching gener-
ation reveals two exponential laws with different scaling factor
for conducting and respiratory airways. For the conducting
part the relation d(z) = d(0) × 2−z/3 was observed for the
diameters d in generation z. For such shrinkage factor in the
diameter the total volume of all branches remains constant
for dichotomous branching, and the entropy generation during
breathing is minimal [29]. The plot was reproduced from [30].
ureteric bud with a pattern characteristic of lung epithelium,
i.e. with increased lateral branching [34]. Mesenchymal tis-
sue that either induced or did not induce branching of an
epithelial layer in culture was found to differ in its mechanical
properties, though the exact differences have not been defined
[35]. In line with these observations, lung branching was
proposed to be driven by the difference in the viscosity of the
luminal / amniotic fluid and the mesenchyme, separated by
a ”skin” of surface tension, the epithelium [31]. Two fluids
with different viscosities exhibit an instability if the more
viscous liquid pushes the less viscous one in response to
an external force (figure 8a); in physics this effect is often
referred to as viscous-fingering (figure 8b) [32], [36]. This
effect, though physically plausible, has later been recognized
as biologically incorrect by the authors [37], [38], because
(1) branching morphogenesis can proceed also without mes-
enchyme, (2) branching morphogenesis can proceed without
growth (hence without growth pressure), and (3) the robustness
of the branching process suggests that the branching process
is highly controlled, which would not be the case for a near-
equilibrium instability.
In subsequent studies the authors studied a similar model,
but interpreted the two (Stokes) fluids as epithelium and
mesenchyme, with surface tension in between and focused on
the effects of an external ”clefting force”, which was assumed
to mainly origin from traction forces in the mesenchyme
(though epithelial forces were considered as well) [38], [39].
Fig. 8: Branching as a result of mechanical differences. (a)
Branching driven by a viscosity difference between the fluid
in the lumen and the mesenchyme; adapted from [31]. (b)
Viscous fingering is observed in a system with two immiscible
fluids of differing viscosities. The panel was adapted from
[32]. (c) and (d) The impact of internal pressure on branching;
adapted from [33].
The analysis showed that the higher the relative viscosity of
epithelium and mesenchyme the wider the resulting clefts and
the faster the clefts emerge [38], [39]. How the position of the
clefting force would be controlled has not been explored, but
this could, of course, be regulated by the signalling networks
that control branching morphogenesis.
Signalling factors play a key role in branching morpho-
genesis, and branching of the epithelium in the absence of
mesenchyme is observed only if the appropriate signalling
factors (i.e. FGF in case of the lung) are added to the
matrigel [40]. Similarly, while increased internal pressure is a
mechanical effect that leads to an increase of lung branching
in in vitro cultures (figure 8c,d), also this effect depends on
the activity of FGF signalling, and is not observed in FgfR2b
null mice, and is reduced in Fgf10 hypomorphic lung explants
[33]. Signalling networks thus appear to be at the core of the
control of branching morphogenesis, and seem to both affect
and to be affected by mechanical properties of the tissue. Thus
signalling networks regulate the hydraulic pressure during
lung organogenesis [41] as well as the actomyosin-mediated
contractility of cells, and local differences in the extracellular
matrix. Inhibition of the actomyosin-mediated contractility in
lung explants decreases branching [42], whereas activation of
the contractility increases branching [43]. The impact of the
ECM structure on branching morphogenesis has previously
been reviewed [44].
C. Signalling Models
The core signalling module that controls branching
morphogenesis in the lung comprises the two diffusible
proteins, FGF10 and SHH (figure 4a); mutations in both
genes and their downstream effectors abrogate branching
morphogenesis [48]–[50], while mutations in other genes at
most modulate the branching process. FGF10 has been shown
to induce the outgrowth of lung buds [11]. FGF10 and SHH
engage in a negative feedback loop, in that FGF10 signalling
induces Shh expression in the epithelium, while SHH
signalling represses Fgf10 expression in the mesenchyme.
1) Diffusion-limited Growth: The emergence of branches
in cultures of mesenchyme-free lung epithelium has been
proposed to be the result of diffusion-limited growth (figure
9a) [45], [51], [52]. The diffusion-limited regime of growth is
observed when the concentration of the growth factor inducing
tissue growth is low and degradation of the growth factor
can therefore result in sharp concentration gradients. Small
protrusions (which are closer to the source) will then expe-
rience higher morphogen concentrations. As a consequence
these protrusions will grow faster and thus get even closer to
the source. In the experiment, mesenchyme-free lung explants
where placed into a matrigel containing FGF. The lung tissue
degrades FGF and thus acts as a sink. At sufficiently low FGF
concentrations a gradient of FGF emerges with a minimum
concentration of FGF in the proximity of the epithelium and
the maximum concentration away from the lung explant. For
such low concentrations irregular growth of the explant is
indeed observed (figure 9a). In the case of high concentrations
of FGF in the matrigel no such gradient can emerge and a uni-
form expansion of the lung explant was observed [45]. When
the conditions of diffusion-limited growth were met, both the
model and the experiments show that the mechanical strength
of the cytoskeleton can only suppress branching. In the chick
lung, a branched structure is formed only dorsally while a
cyst structure (air sac) is formed ventrally during development.
Miura and collaborators suggest that this difference can be
accounted to differences in the FGF10 diffusivity that would
be sufficiently low only on the dorsal side for branching pattern
to emerge by diffusion-limited growth [53].
A further mechanism, similar to the diffusion-limited
growth, has been proposed to explain lung branching in vivo.
Here, however, the authors assume that the FGF concentration
on the epithelium is equal everywhere because the epithelium
efficiently absorbs the growth factor [46], [54]. What is
assumed to differ is the steady state FGF10 gradient between
mesothelium and epithelium. Assuming that FGF10 is uni-
formly expressed in the sub-mesothelial mesenchyme and FGF
receptors are expressed only in the epithelium (such that there
is no FGF degradation in the mesenchyme), then the steepness
of the steady-state FGF10 gradient between mesothelium
and epithelium would depend only on the distance between
these tissue layers. If, similar as in the in vitro experiments,
some part of the bud was closer to the mesothelium than
others, then this part of the bud would experience a steeper
FGF10 gradient. If cells could sense gradients rather than
concentrations then this could, in principle, drive self-avoiding
outgrowth of the branch (figure 9b). Moreover, given that the
distance between source and sink is key to this mechanism,
all buds remain at a comparable distance of the mesothelium
during growth. This distance is controlled by the mesenchyme
proliferation rate relative to the epithelial proliferation rate.
The authors also found that the computed branched tree
reproduced multiple morphometric characteristics that have
been measured in the adult human lung (i.e. the distribution
of branch lengths, diameters and the asymmetry ratio) at least
qualitatively. However, in experiments, in which FGF10 was
added to lung cultures, the mRNA expression of the FGF10
target Sprouty2 was found to be upregulated [55]. This result is
consistent with a model, in which cells respond to the FGF10
concentration, but is difficult to explain with a gradient-based
mechanism, as the homogenous addition of FGF10 should
reduce the gradient and should thus result in a lower expression
level.
We note that stereotyped branching could be obtained
with diffusion-limited growth only, if there was a preceding
mechanism in place to generate the same irregularities in
the starting geometry for all buds, so that diffusion-limited
growth would be initiated always at the same location to
obtain the same overall branching pattern.
2) Distance-based Patterning: In an alternative model, a
different distance-dependent effect has been proposed based
on the regulatory interactions between SHH and FGF10
[11]. SHH signalling represses Fgf10 expression, but Shh
is expressed only in the epithelium, and Fgf10 is expressed
only in the mesenchyme (figure 4a). Accordingly, it has
been proposed that the inhibitory effect of SHH on Fgf10
expression will be the stronger, the thinner the mesenchyme.
Thus, it has been argued that a locally thinner mesenchyme
would lead to the local repression of Fgf10 expression, and
thus to the accumulation of FGF10 on the sides, thereby
triggering bifurcating outgrowth. Hirashima and coworkers
studied a computational implementation of the model on
a static 2-dimensional domain in the shape of lung bud
cross-section [23]. The model focused on the interactions
between FGF10, SHH, and transforming growth factor
(TGF)-beta. According to the model TGF-beta is restricted
to the stalk and prevents Fgf10 expression, while SHH
is restricted to the tip and enhances Fgf10 expression at
low concentrations and represses Fgf10 expression at high
concentrations. As a result FGF10 is concentrated at the tip as
long as the bud is sufficiently far away that the concentration
of SHH is low (figure 9c). As the tip grows closer to the
impermeable boundary, the local SHH concentration increases
and suppresses Fgf10 expression. As a result, the FGF10
Fig. 9: Patterning models based on the local variations in the distance of the epithelium from the source of FGF10. (a) Branching
as a result of diffusion-limited growth. Tissue (delimited by white line) that is placed into a solution with a low concentration
of an outgrowth-inducing signalling factor (such as FGF10 in the lung) will degrade the signalling factor and thus induce a
concentration gradient (red - high, blue - low). As a result of small irregularities in the tissue shape (white line), some part of the
tissue will be closer to the higher concentration and accordingly start to grow out faster, thus experiencing even higher (relative)
concentrations. The panel was reproduced from [45]. (b) With FGF10 produced mainly in the sub-mesothelial mesenchyme
and its receptor produced only in the epithelium, an FGF10 gradient can be expected to emerge. If the FGF10 concentration is
homogenous close to the mesothelium and on the epithelium, then the gradient would be steeper the shorter the distance between
epithelium and mesothelium. If cells read out gradients rather than concentration, then small differences in the distance could
trigger self-avoiding outgrowth of branches. The panel was reproduced from [46]. (c-e) Distance-based mechanism based on
SHH and FGF10. SHH is produced only by the epithelium, and represses Fgf10 expression at high concentrations. Accordingly,
Fgf10 expression can be expected to be lower, the closer epithelium and mesothelium [11]. (c) Assuming that SHH induces
Fgf10 expression at low concentrations, the FGF10 concentration is high as long as the bud is sufficiently far away from the
boundary, thus supporting bud elongation. (d) As the bud approaches the impermeable boundary, the FGF10 profile splits, thus
supporting bifurcating outgrowth. (e) The bifurcation in panel d requires an impermeable boundary and is not observed on an
open domain. The FGF10 distribution in panels (c)-(e) was calculated according to the model presented in [23]; panels (c)-(e)
were adapted from [47].
profile splits (figure 9d). While the regulatory interactions
in the model are plausible, the mesothelium that surrounds
the lung bud is unlikely to present a diffusion barrier. In
fact, culture experiments show that protein ligands that are
added to the lumen of cultured lungs cannot diffuse to
the mesenchyme, but protein ligands that are added to the
culture medium can pass through the mesothelium to regulate
the mesenchyme [56]. Without an impermeable mesothelial
boundary the mechanism does not lead to a bifurcating profile
(figure 9e) [47]. We note that this distance-based mechanism
would also not explain the lateral branching mode. It is
therefore likely that a different mechanism controls branching
morphogenesis in the lung.
3) Diffusion-based Geometry Effect: In vitro experiments
demonstrate that the geometry of the domain can affect its
patterning [58]. Thus, as a result of diffusion, more signals
are lost at the edges of a domain than in its center, if a signal-
producing domain is embedded in a non-producing domain,
and the signal can diffuse. As a result of this geometry effect,
signal then concentrates in the center of the domain (Fig.
10a). If this factor supports outgrowth of the tissue, then a
bud can form. As the bud elongates, more signal is lost at
the tip than at the sides, because of the higher curvature, and
Fig. 10: Branching as a result of a diffusion-based geometry
effect. (a) A cartoon of the proposed geometry-based branch-
ing mechanism. As a result of stronger diffusion-based loss
at the edges, the concentration of the signal is highest in
the center of the domain (red line), and drives the outgrowth
of a bud. As the bud elongates, more signal is lost at the
tip than at the sides, because of the higher curvature, and
a bifurcating concentration profile of the signalling factor
emerges. Computational studies confirm that the geometry
effect results in bifurcating concentration profiles, but reveals
that it does not support bifurcating outgrowth (Menshykau
and Iber, unpublished observation). (b) The simulated con-
centration profile of a ligand that is uniformly secreted from
the epithelium of extracted 3D chicken lung bud (Hamburger-
Hamilton stage (HH) 27+) into a large computational bounding
box. The concentration profiles were normalized to the highest
value (red - highest relative concentration; blue - lowest) (c) A
three-dimensional solid model representation of the region of
highest ligand concentration represented by the red shading.
Panel (H) shows the morphogen concentration in a cross-
section through a bud. The bud stalk and branch point have
a local maximum (solid white triangles) whereas the bud tip
has a local minimum (empty black triangles) in the predicted
ligand concentration. Panels b,c and their legends were adapted
from [57].
a bifurcating concentration profile of the signalling factor
emerges. Computational studies confirm the emergence of a
bifurcating profile as a result of a diffusion-based geometry
effect, but also show that it does not support bifurcating
outgrowth (Menshykau and Iber, unpublished observation).
The geometry effect may nonetheless play an important role
in branching morphogenesis by inducing an initial pattern,
Fig. 11: A receptor-ligand based Turing model for lung
branching morphogenesis. (a-b) The regulatory network shown
in figure 3f gives rise to a Turing pattern and results in
distributions of FGF10 (colorcode, red - highest, black -
lowest) and SHH (black & white contour line plot) on bud-
shaped domains as characteristic for (a) bifurcation or (b)
lateral branching events. (c) The FGF10 concentration profile
along the lung bud. (d) An extended network that includes also
FGF9 also reproduces the observed patterns of smooth muscle
(SM) formation from progenitors (PR) and Vegfa expression
during lung branching morphogenesis. (e) Smooth muscles
(colour code) emerge in the clefts between lung buds (contour
lines mark FGF10 concentration levels) as the lung bud grows
out. (f) Vegfa expression, an inducer of blood vessel formation,
emerges in the distal sub-epithelial mesenchyme. Panels (a-c)
were adapted from [47] and panels (d-f) from [59].
that can then be ”fixed” by other processes. When 3D
shapes of lung bud epithelia were used in a simulation, that
had been extracted from early developing chicken lungs,
simulated secretion of a ligand from the epithelium into a
large computational bounding box (that would model the
mesenchyme) resulted in a steady-state concentration pattern
that approximately coincided with where the authors would
expect branching of secondary bronchi to be inhibited (Fig.
10b,c) [57].
4) Ligand-Receptor-based Turing Mechanism: We have
recently proposed a ligand-receptor based Turing mechanism
to explain the stereotyped branching processes in the lung [47].
We showed that the reported biochemical interactions between
FGF10, SHH, and PTCH1 (figure 4a) give rise to a Turing
pattern [60] that yields the FGF10 patterns, which represent
the two modes of branching in the developing lung: bifurcation
and lateral branching (figure 11a,b). The initial model analysis
was carried out on a 2D slice of the lung bud. Importantly,
the Turing pattern not only permitted the emergence of rings
(cylindrical symmetry) but also of spotty patterns on a 3D
lung bud shape (rotational symmetry) (figure 5). Mutations
in genes that are not part of the FGF10/SHH core patterning
module have been shown to affect the branching pattern. We
find that alterations in almost any parameter value can switch
the branching mode in our model. The impact of these other
gene products on the branching pattern can thus be explained
with indirect effects, i.e. by affecting the parameter values
of the core model. Another interesting parameter value is the
growth rate. We observed bifurcating patterns at low growth
speed and lateral branching patterns at fast growth speed.
Interestingly, we found that the FGF10 concentration differs
in the spots that emerge during lateral branching (figure 11c).
If the outgrowth speed depended on the FGF10 concentration
then these different concentrations might explain the different
branching sequences observed for different branches.
Including FGF9, which is expressed in the distal mesothe-
lium (figure 11d, blue line), and which enhances the expression
of Fgf10, promoted lateral branching over the bifurcation
mode of branching as observed in the embryo. Further simu-
lations showed that the expanded core regulatory network was
capable of controlling the emergence of smooth muscles in
the clefts between growing lung buds (figure 11e), and Vegfa
expression, an inducer of blood vessel formation, in the distal
sub-epithelial mesenchyme (figure 11f) [59]. In how far the
vasculature impacts back on the branching pattern is still a
matter of investigation. Thus, while ablation of the vasculature
impacted on the 3D branching pattern in that branches formed
parallel or at a shallow angle instead of perpendicular to the
axis, the authors noted that ”inhibition of normal branching
resulting from vascular loss could be explained in part by
perturbing the unique spatial expression pattern of the key
branching mediator Fgf10 and by misregulated expression of
the branching regulators Shh and Sprouty2” [61].
Another open question concerns the relative width and
length of branches. The proposed Turing mechanism would
only explain branch point selection and the choice of the
branching mode. How the diameters of the developing
bronchial tree are determined relative to the length of each
branch element is still an open question. Recent experiments
suggest that signalling by extracellular signal-regulated kinase
1 (ERK1) and ERK2, a downstream target of FGF signalling,
plays an important role because it affects the cell division
plane [62]. A bias in the cell division plane can bias tissue
growth in a direction and thus result in either elongation or in
a widening of the stalk. Cells that divide parallel to the airway
longitudinal axis have lower levels of ERK1/2 signalling and
removal of Sprouty genes, which encode negative regulators
of FGF10 signalling, results in the random orientation of cell
division planes in the stalk and in airways that are wider and
shorter than normal [62].
II. KIDNEY BRANCHING MORPHOGENESIS
Similar to the lung, the kidney collecting ducts form via
branching of an epithelial cell layer. During kidney develop-
ment the ureteric bud invades the metanephric mesenchyme
around embryonic day (E) 10.5 [63]. According to culture
experiments most branching events in the kidney are terminal
bifurcations and to a lesser extent trifurcations, and only 6%
of all branching events are lateral branching events [3]–[5].
FGF10 is not necessary for branching in the lung as branching
is still observed in Fgfr2-mutant mice, though at a reduced rate
[64]. Core to the branching mechanism appears to be the TFG-
beta family protein GDNF. It is expressed in the mesenchyme
and signals via its receptor (RET) and co-receptor GDNF
family receptor alpha (Gfrα)1 in the epithelium (figure 4d);
Gdnf, Ret, and Gfrα1 null mice do not develop kidneys [5],
[17]–[19], [63], [65], [66]. FGF and GDNF signalling appear
to cooperate since activation of FGF10-FGFR2 signalling by
knocking out the antagonist Sprouty can rescue Gdnf−/− and
Ret−/− mutants, which otherwise fail to develop kidneys [67].
Moreover, GDNF and FGF10 signalling have at least in part
the same transcriptional targets [68]. This suggest that the
branching mechanisms for lung and kidney are somewhat
related in spite of their at first sight different molecular nature.
An important difference, however, concerns the core feedback
structure. While FGF10/SHH engage in a negative feedback in
the lung, GDNF engages in a positive feedback with WNT11
in the ureteric bud [63].
Beads soaked with GDNF induce the outgrowth of extra
ureteric buds in kidney culture explants [5], [17]–[19], [63],
[65]. Based on the chemoattractive properties of GDNF [20],
[69], it was suggested that branching of the ureteric bud is
caused by the attraction of the tips toward local sources of
GDNF [70]. Accordingly, in early theoretical work the ureteric
bud shape was proposed to be controlled by the interplay
of cell proliferation and cell chemotaxis [71]. If chemotaxis
towards a source of growth factors (i.e. GDNF) dominates
relative to the general growth then the computed branched
structure is kinked with clearly discernible buds. On the other
hand, if growth dominates relative to chemotaxis then the
developing bud is rather round. The model did not attempt to
address the question of how a split expression pattern emerges
in the first place. Rather, given the split expression of the
signalling protein Gdnf (as hard-coded in the model), the
model addressed the different possible bud shapes.
We have recently developed a 3D model for branching mor-
phogenesis in the kidney [72]. Here we noticed that, similar
as in the lung, the reported biochemical interactions between
GDNF and its receptors (figure 4d) result in a Turing pattern.
Much as reported for the embryo, split concentration patterns
as characteristic for bifurcations (Fig. 12b) and trifurcations
(Fig. 12c) dominate in the model for physiological parameter
values, while elongation (Fig. 12a) and subsequent lateral
branching (Fig. 12d) are rather rare. The patterning mechanism
can also support the invasion of the uretric bud into the
metanephric mesenchyme (Figure 13a,b). It is thus possible
Fig. 13: Branching of the Ureteric Bud into the Metanephric Mesenchyme. (a) The computational domain for the simulation
of an ureteric bud after it has started to branch from the Wolffian duct into the metanephric mesenchyme. The double arrows
illustrate the stalk length and the mesenchyme thickness. (b) The branching of the ureteric bud into the metanephric mesenchyme
in response to GDNF signalling. Here the bud grows out normal to its surface and at a speed proportional to the local
concentration of the GDNF-receptor complex, as described in [73]. (c) The dependency of the length of the stalk to the first
branching point on the thickness of the mesenchyme (both as defined in panel a). (d) The branching of the ureteric bud into
the metanephric mesenchyme in a Sprouty−/− mutant. The concentration of the GDNF-bound RET complex in the epithelium
is indicated as greyscale colour code (white - highest, black - lowest); the strength of Gdnf expression in the mesenchyme is
represented by a rainbow colour code (red - highest, blue - lowest). The panels were adapted from [72].
Fig. 12: Receptor-ligand based Turing model for kidney
branching morphogenesis. The reported regulatory interactions
shown in figure 4d can result in self-emerging patterns of the
GDNF-bound RET complex in the epithelium (greyscale with
white - highest, black - lowest), and Gdnf expression in the
mesenchyme (rainbow colour code with red - highest, blue -
lowest), when solved on a 3D idealized bud-shaped domain.
The different patterns can, in principle, (a) support elongation,
or support the formation of (b) bifurcations, (c) trifurcations,
or (d) lateral branching. The panels were adapted from [72].
that the induction and outgrowth of the ureteric bud from the
Wolffian duct works by the same mechanism. Interestingly, in
case of thicker mesenchyme the length of the outgrowing stalk
is shorter and branching happens earlier (Figure 13c). This is
in good agreement with experimental observations in the lung
where side-branching was noted to occur when sufficient space
becomes available around the circumference of a parent branch
[74].
Turing mechanisms have been proposed for many other
biological patterning phenomena, and reproduce the size and
geometry-dependence of biological patterns of various com-
plexity [60], [75]. In spite of the great similarity of simulated
and real patterns, it remains to be established whether Turing-
type mechanisms rather than alternative mechanisms underlie
their establishment [76]. In fact in several cases, Turing-type
mechanisms have been wrongly assigned to patterning pro-
cesses, e.g. to explain the stripy expression pattern of pair-rule
genes that emerge during Drosophila development [77]. These
failures reveal the importance of a careful and comprehensive
analysis of the underlying molecular interactions. That this is
still not always done is largely due to the lack of sufficient
information regarding the chemical properties of the morpho-
regulatory proteins (half-life, diffusion rates, endogenous con-
centrations, activities etc.) and the molecular nature of their
interactions (activating, inhibitory etc.). Mutant phenotypes, if
considered comprehensively rather than selectively, can also
provide valuable information to challenge Turing models.
In the case of lung and kidney branching morphogenesis,
we showed that, for the identified network components, the
Turing model reproduces all available mutant phenotypes. In
particular, in case of lung branching morphogenesis allelic
sequences of the Fgf10 knock-downs are available. Computa-
tional modeling showed that the inter-bud (inter-spot) distance
is constant as the Fgf10 expression rate is reduced from 100%
to 50%, but it greatly increases as the Fgf10 expression rate
decreases below 50% [59]. This is in perfect agreement with
the experimental results that show that WT, Fgf10LacZ/+, and
Fgf10+/− have normal phenotypes and Fgf10 expression be-
tween 50-100%, while Fgf10 expression in Fgf10LacZ/− mice
is reduced to below 50 % and an abnormal phenotype with an
increased distance between branching points is observed [78],
[79]. For kidney branching morphogenesis a Wnt11/Ret allelic
series has been reported [80] and much as in the simulations
the phenotype of Wnt11 and Ret double mutants become more
severe as the expression of both Ret and Wnt11 decreases [72].
Finally, in Sprouty mutants several ureteric buds branch from
the Wolffian duct, as also observed in the simulation (Fig.
13d).
A receptor-ligand based Turing mechanism is thus an at-
tractive candidate mechanism for the control of branching
morphogenesis in both lung and kidney, in spite of the different
proteins involved. In the following, we will compare the core
networks that control branching morphogenesis in glands to
the ones in lung and kidney.
III. BRANCHING MORPHOGENESIS IN GLANDS
A. Salivary Glands
The signalling proteins that regulate branching morphogen-
esis in the salivary gland are well characterized, and FGF
signalling is necessary for branching morphogenesis (figure
4b). Thus transgenic mice lacking FGF8, FGF10, FGFR2b, or
EGFR do not develop further than the initial bud stage (Fgf8-
conditional null mice, Fgf10-null, and Fgfr2b-null mice), or
they have substantially fewer terminal buds (Egfr-null mice)
[14]. FGF signalling represses Wnt expression [81]. WNT
signalling upregulates the expression of Eda in mesenchymal
cells and EDA upregulates Shh expression in epithelial cells
via NF-kB signalling [82]. SHH signalling upregulates Fgf8
expression [83], which in turn upregulates Fgf10 and Shh
expression [84]. Removal of the Eda receptor or Shh results in
dysplasia [83]. Knock-out of Bmp7 results in reduced branch-
ing, and BMP7 is able to rescue branching in salivary glands
treated with the FGFR signalling inhibitor SU5402, suggesting
that BMP7 may be downstream of FGFR signalling, or in
a parallel pathway [85]. The receptor-ligand interactions are
thus very similar to those in the lung (e.g. FGF10-FGFR2b
or SHH-PTCH1) and kidney (i.e. WNT and FGF10), and
mesenchyme from lung buds can induce branching of cultured
submandibular epithelium [35]. Given these parallels, a similar
Turing-based mechanism may control branching also in the
salivary gland. Experiments, in which the FGF10 diffusivity
was modulated by alteration of the binding affinity of FGF10
for heparan sulfate, highlight the relevance of a diffusion-based
mechanism as they reveal an effect on the branching pattern
(elongation versus branching) in the salivary gland [13].
B. Pancreas
In contrast to the classical epithelial budding and tube
extension observed in other organs, a pancreatic branch takes
shape as a multi-lumen tubular plexus and coordinately ex-
tends and remodels into a ramifying, single-lumen ductal
system [86]. This initial tube formation takes place from
E9.5 to E12.5. During a secondary transition from E13 to
birth, branching morphogenesis is observed [87]. In vivo time
lapse imaging reveals that the main mode of branching during
pancreas branching morphogenesis is lateral branching (86%);
terminal bifurcations are also observed, however less often
(14%) [88]. The lateral branching mode deployed during
pancreas development is simpler than that in the case of
lung branching - new buds appear predominantly on one side
of the outgrowing tip. However, this might be an artifact
of the culture experiment, e.g. lung branching patterns are
known to be different in vivo and in vitro. Similar to lung
branching morphogenesis both FGF10/FGFR2b [15], [16], and
SHH/PTCH1 receptor-ligand modules play an important role
during pancreas branching morphogenesis, with Hedgehog
signalling repressing Fgf10 expression (figure 4c) [89]. Two
factors, BMP4 and FGF10, promote pancreatic morphogenesis
at the primary stages of the organogenesis. Bmp4 is the first
to be expressed and promotes budding formation, whereas
Fgf10 is expressed later and promotes (among other things)
branching of the pancreatic bud [15]. Ephrin signalling has
also been implicated in pancreatic branching as removal of
the EphB2 and EphB3 receptors results in shortened branches
and smaller pancreata [86]. The developing pancreas displays
predictable trends in overall shape and in the elaboration of
specific branches [86]. The early stages have been simulated
using a fully executable, interactive, visual model for 4D
simulation of organogenic development [90]. A computational
model of the later developmental stages, including the branch-
ing morphogenesis of the exocrine pancreas, is still required
as is a model of the processes that result in the differentiation
of the pancreatic tissue into ducts and enzyme secreting acinar
cells at the tips of the branches.
C. Prostate
Circulating androgens initiate the development of the
prostate from the urogenital sinus [12]. The androgen receptor
is expressed in the mesenchyme and is necessary for budding
of the urethral epithelium [12]. Androgens have been shown
to induce the expression of Fgf10 and FGF receptor 2 (Fgfr2)-
IIIb in the urethrea [91]. FGF7 and FGF10, expressed in
the mesenchyme, bind to FGFR2 on epithelial cells, which
leads to the induction and maintenance of Shh expression
[12]. SHH signalling, in turn, downregulates Fgf expression
[12]. Moreover, ductal branching and budding are inhibited
by the mesenchymal signalling factors BMP4 and BMP7, and
stimulated by the antagonist of these BMPs. The regulatory
loop is thus very similar to the one in the lung (figure 4a), and
FGF10 has been found to be essential for the development of
the fetal prostate [92]. It should be noted that most of the ducts
remain unbranched until birth in rodents but, subsequently,
epithelial-mesenchymal interactions result in further elonga-
tion and branching morphogenesis.
D. Mammary Glands
The development of the mammary proceeds in three stages:
a rudimentary gland develops in the embryo and remains qui-
escent until puberty [93]. During puberty extensive branching
occurs, and the mammary glands will undergo further rounds
of branching during pregnancy. In male mice, the mesenchyme
surrounding the stalk continues to condense until it severs
the bud resulting in a greatly diminished ductal system [94].
Signalling of parathyroid hormone-like hormone (PTHLH) via
Type1 PTH/PTHLH receptor (PTH1R) appears to play a key
role in the initial process of generating a rudimentary ductal
system before birth [95]. Pthlh is expressed in the epithelium
and signals through its mesenchymal receptor PTH1R to
modulate WNT signalling, and to induce the BMP receptor-
1A (BMPIRA) in the mesenchyme [96]. BMP4 signalling can
rescue ductal outgrowth in cultures of Pthlh−/− mammary
buds [96].
Similar to the lung and the kidney, epithelial-mesenchymal
signalling by FGFs, EGFs and WNTs plays an important
role in controlling branching morphogenesis [93], [97]. FGF
receptor 2 is required on epithelial cells for ductal elongation
[21], but a unique chemoattractant like FGF10 in the lung
and salivary gland [98] or GDNF in the kidney [20], [69]
has not been identified [7]. TGF-β signalling, on the other
hand, has been shown to be important to reduce branching and
thereby restrict branch formation [58], [99]. TGF-β signalling
has been shown to induce the deposition of extracellular matrix
[58], [99] and to affect basal cell proliferation via roundabout
1 (ROBO1), SLIT2, and WNT signalling [100]; the non-
canonical WNT signalling member WNT5a is necessary for
the effects of TGF-β on branching morphogenesis [101].
Culture experiments support a similar control mechanism
for branching morphogenesis as in the other organs, as
mesenchyme from the salivary gland induces branching of
the mammary gland epithelium, even though the branched
structure and lobe resemble then that of the salivary gland
[102]. Contrary to the lung and the kidney, branching
in the mammary glands is, however, not stereotyped [7],
[97]. The mechanisms that have been proposed to control
branching morphogenesis in the mammary gland, have so
far mainly focused on mechanical constraints, as provided
by interactions with the extracellular matrix [44], [103], and
on diffusion-based geometry effects (Fig. 10a) [58], [104].
Experiments support an influence of mechanical stress on
branching morphogenesis in mammary glands [105], but the
composition of the ECM is likely the result of regulation by
signalling networks [58], [99].
IV. A GENERAL MECHANISM FOR THE CONTROL OF
STEREOTYPED BRANCHING?
The early branching events differ between the organs (figure
1), but are highly stereotyped (at least in lung and kidney),
and must therefore be carefully controlled. A number of
mechanisms have been proposed, but most fail to meet all
key aspects of such a branching mechanism, which are: 1) the
production of stereotyped pattern from noisy initial conditions,
2) pattern stability (or pattern fixation) during outgrowth, such
that the pattern can support the outgrowth of the branch,
and 3) the ability to control branching morphogenesis in
different organ systems with different signalling networks.
The receptor-ligand based Turing mechanism meets all these
conditions [47], [59], [72]. In particular, it works with a
range of signalling networks, because all signaling involves
Fig. 14: Cooperative receptor-ligand interactions can give rise
to Turing patterns. The depicted receptor-ligand interaction
can result in spatial patterns via Schnakenberg-type reaction
kinetics. Here m receptors (R) and n ligand molecules (L)
(with m + n > 2) need to bind to form the complex RmLn.
The receptor ligand complex then up-regulates the receptor
concentration (by increasing its expression, by limiting its
turn-over, or similar). To obtain Turing patterns, ligands must
diffuse much faster than their receptors. As characteristic for
Schnakenberg-type Turing pattern, the highest receptor and
ligand concentrations are then observed in different places.
the interaction of secreted ligands with some receptors (figure
4), and any ligand-receptor pair that fulfills the following three
conditions can give rise to Turing-type reaction kinetics:
1) The ligand must diffuse faster than its receptor, which
is generally the case for soluble ligands and membrane
receptors [106]–[109].
2) Receptor and ligand must interact cooperatively, which
is typically the case when multimeric components bind
each other.
3) Receptor-ligand binding must result in increased recep-
tor production. This has been documented in case of
SHH/PTCH1 [110], and GDNF/RET [65], [68], [111].
In case of FGF10 both up- and down-regulations have
been reported [112]–[115]. BMPs as well as other
ligand-receptor systems would also meet the require-
ments [116], [117].
The ligand-receptor based Turing mechanism is different
from the classical activator-inhibitor Turing mechanism, also
known as Gierer-Meinhardt Turing mechanism [118], which is
the most commonly studied Turing mechanism. Unlike in the
activator-inhibitor mechanism, only one ligand is required in
the here-proposed mechanism, and the two components (ligand
and receptor) assume their highest (and lowest) concentrations
in different places (figure 14). The ligand-receptor mechanism
is based on Schnakenberg-type reaction kinetics [119], which
correspond to the activator-depleted substrate Turing mecha-
nism [118].
Turing mechanisms have been proposed for many systems,
and also an alternative Turing-based model has previously
been proposed that achieved branching morphogenesis by a
combination of patterning and fixation events via cell differen-
tiation [120]. Further experimental studies are now required to
carefully test the proposed mechanisms. Turing patterns, much
as the other proposed mechanisms, are very sensitive to the
geometry of the domain. Simulations of the models on realistic
embryonic geometries would therefore present a good test to
the model. Developmental sequences of 3D geometries can
now be obtained with optical projection tomography (OPT)
[121], two photon or light sheet microscopy [122], [123].
Software packages are readily available to construct the 4D
geometric series and to efficiently simulate the signalling
models on the growing and deforming domains [73], [124],
[125]. The correct mechanism should be able to predict the
branch points.
Current models typically consider tissue as a continuum,
without cellular resolution. Cell boundaries, however, can have
important effects, in particular in the ligand-receptor based
Turing mechanism, where receptor is restricted to the surface
of single cells. While we have previously shown that similar
patterns can be obtained also on a static, cellularized domains
[47], it will be important to develop simulation tools that
permit the efficient simulation of patterning in 3D cellular
systems. Here it will be important to include cell growth,
diffusion of soluble factors as well as diffusion restrictions
imposed by cell boundaries to membrane and cytoplasmic
proteins.
Finally, it will be important to address the issue that
classical Turing models produce patterns only for a tiny
parameter space. For such small parameter space it is difficult
to explain how patterns could emerge in the first place and
how they could be preserved during evolution.
V. CONCLUSION
Branching morphogenesis has long fascinated biologists
and theoreticians and many different effects have been defined
that all impact on the branching process. We propose that
Turing patterns as a result of receptor-ligand interactions
constitute a general core mechanism that controls branching
morphogenesis in the different organs, as well as other
patterning processes in the various developmental systems.
Much as complex fractal patterns can be generated with
few rules, Turing mechanism can, in principle, implement
a complex stereotyped sequence of branching events based
on few interacting proteins. It should be noted that fractals
and Turing patterns are otherwise very different, and Turing
mechanisms do not give rise to fractal patterns. An additional
mechanism must therefore define the diameter of the tubes to
eventually give rise to a fractal-like sequence in the adult.
Many of the other discussed effects are likely to affect
the patterning process without being its key controller. One
such important effect is likely the diffusion-based geometry
effect (figure 10) [58], which biases the pattern, but which
cannot support bifurcating outgrowth by itself. Moreover, the
distance between the Fgf10-expressing distal mesenchyme
(close to the mesothelium) and the Shh-expressing epithelium
can be expected to affect the exact lung branching pattern
without being responsible for the bifurcating concentration
profiles per se [11]. Similarly, mechanical differences are
clearly affecting the branching process. How these arise
and how they are controlled in space and time will be an
important direction of future research.
A key open question concerns the mechanism that mediates
branch outgrowth once an initial symmetry break in the
cellular signalling has defined the branch points. This is
likely the result of a combination of local changes in the
proliferation of cells (in particular their cell division plane),
cell deformation, and cell migration [62], [126]–[128].
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